ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Venus Medtech (Hangzhou), Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.30%
EBIT Growth (5y)
-26.59%
EBIT to Interest (avg)
-46.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.12
Tax Ratio
1.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.47
EV to EBIT
-3.58
EV to EBITDA
-5.00
EV to Capital Employed
0.50
EV to Sales
2.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.10%
ROE (Latest)
-30.77%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD -567.9 MM
NET PROFIT(HY)
Higher at HKD -298.78 MM
-9What is not working for the Company
INTEREST(HY)
At HKD 11.85 MM has Grown at 59.65%
RAW MATERIAL COST(Y)
Grown by 49.11% (YoY
CASH AND EQV(HY)
Lowest at HKD 312.31 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.96 times
NET SALES(Q)
Lowest at HKD 130.99 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -144.96 %
Here's what is working for Venus Medtech (Hangzhou), Inc.
Net Profit
Higher at HKD -298.78 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Operating Cash Flow
Highest at HKD -567.9 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Here's what is not working for Venus Medtech (Hangzhou), Inc.
Interest
At HKD 11.85 MM has Grown at 59.65%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Net Sales
Lowest at HKD 130.99 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Net Sales
Fallen at -49.71%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Operating Profit Margin
Lowest at -144.96 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Cash and Eqv
Lowest at HKD 312.31 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 0.96 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 49.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
